RXLProShares Ultra Health Care
RXL Fund Description
RXL provides 2x leveraged exposure to a cap-weighted index of US health care companies.
RXL Factset Analytics Insight
RXL delivers daily 2x returns of the Dow Jones US Health Care Index, a broad, cap-weighted health care index that includes pharma, biotech, healthcare services and equipment companies. The fund will likely tilt towards pharma and healthcare equipment firms given their vast cap, thus RXL is somewhat of a short-term bet on the movements in these industries. Investors should be cognizant of the fund's daily rebalancing, which can lead to profound differences in expected returns over the long haul. Still, compounding is a double-edged sword, it can work in investors' favor in trending markets. Over longer periods, returns can vary significantly from its headline 2x target returns.
RXL MSCI ESG Analytics Insight
ProShares Ultra Health Care has an MSCI ESG Fund Rating of BBB based on a score of 5.36 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. ProShares Ultra Health Care ranks in the 37th percentile within its peer group and in the 44th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
RXL Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of RXL. RXL is rated a N/A out of 5.